[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
February 28, 2000

Celecoxib-Induced Acute Pancreatitis and Hepatitis: A Case Report

Arch Intern Med. 2000;160(4):553-554. doi:

Celecoxib (Celebrex; Searle & Co Pharmaceuticals, Skokie, Ill, and Pfizer Inc, New York, NY) is a new and popular nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits cyclooxygenase 2.1 It is approved for the treatment of both rheumatoid arthritis and osteoarthritis. Recognized adverse reactions include gastrointestinal hemorrhage, hepatitis, abdominal pain, and diarrhea. It should not be administered to patients with allergies to sulfa drugs. Acute pancreatitis has not been reported with the use of celecoxib.

First Page Preview View Large
First page PDF preview
First page PDF preview